T1	Post-eligibility 0 31	Signed written informed consent
T2	Person 34 37	Age
T3	Value 38 46	18 to 65
R1	Has_value Arg1:T2 Arg2:T3	
T4	Qualifier 49 55	Normal
T5	Qualifier 60 67	healthy
T6	Temporal 178 205	during the screening period
T7	Reference_point 189 205	screening period
R2	Has_index Arg1:T6 Arg2:T7	
T8	Observation 104 119	medical history
T9	Procedure 121 134	physical exam
T10	Measurement 136 147	vital signs
T11	Measurement 152 177	clinical laboratory tests
T12	Scope 104 177	medical history, physical exam, vital signs and clinical laboratory tests
R3	Has_qualifier Arg1:T12 Arg2:T5	
R4	Has_qualifier Arg1:T12 Arg2:T4	
R5	Has_temporal Arg1:T12 Arg2:T6	
T13	Measurement 231 268	quantitative IgA immunoglobulin level
T14	Value 273 306	lower than 15% below normal range
R6	Has_value Arg1:T13 Arg2:T14	
T15	Context_Error 208 368	If all lab results for quantitative IgA immunoglobulin level are lower than 15% below normal range, the subject may not proceed further in the screening process
T16	Undefined_semantics 371 475	Subject must meet all required subject suitability criteria that pertain to normal source plasma donors.
T17	Measurement 486 498	HIV serology
T18	Value 477 485	Negative
T19	Temporal 499 522	during screening period
T20	Reference_point 506 522	screening period
R7	Has_index Arg1:T19 Arg2:T20	
R8	Has_value Arg1:T17 Arg2:T18	
R9	Has_temporal Arg1:T17 Arg2:T19	
T21	Condition 573 581	smallpox
T22	Procedure 559 568	immunized
R10	AND Arg1:T22 Arg2:T21	
T23	Temporal 587 641	3 years prior to commencement of screening assessments
R11	Has_temporal Arg1:T22 Arg2:T23	
T24	Reference_point 604 641	commencement of screening assessments
R12	Has_index Arg1:T23 Arg2:T24	
T25	Non-query-able 643 776	and vaccination history must be confirmed by oral or written history and the presence of a visible pathognomonic smallpox vaccination
T26	Person 784 790	Female
T27	Condition 803 825	childbearing potential
T28	Procedure 861 882	birth control methods
R13	AND Arg1:T26 Arg2:T27	
R14	AND Arg1:T26 Arg2:T28	
